Greater Occipital Nerve Blockade for Cluster Headache
Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with gre...
Gespeichert in:
Veröffentlicht in: | Cephalalgia 2002-09, Vol.22 (7), p.520-522 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 522 |
---|---|
container_issue | 7 |
container_start_page | 520 |
container_title | Cephalalgia |
container_volume | 22 |
creator | Peres, MFP Stiles, MA Siow, HC Rozen, TD Young, WB Silberstein, SD |
description | Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P< 0.003, P = 0.003, P< 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache. |
doi_str_mv | 10.1046/j.1468-2982.2002.00410.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_72098053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1046_j.1468-2982.2002.00410.x</sage_id><sourcerecordid>72098053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</originalsourceid><addsrcrecordid>eNqNkDtPwzAYRS0EouXxF1AmtoTPjzj2wABRaZEqygCz5TgOJKRNsRto_z0JqWCEyZbuudfWQSjAEGFg_KqKMOMiJFKQiACQCIB12fYAjX-CQzQGSmmIgbAROvG-AoCYAz9GI0wIhVjSMYqnzuqNdcHCmHJdbnQdPFj3YYPbujFvOrdB0bggrVvfQzOrc21e7Rk6KnTt7fn-PEXPd5OndBbOF9P79GYeGiY4hJriJBNYGpazgudFnhX9AJMmIUIXRMqcUY11ATgWlIhcWo4Flzzpkiwh9BRdDrtr17y31m_UsvTG1rVe2ab1KiEgBcS0A8UAGtd472yh1q5cardTGFSvTFWqN6N6M6pXpr6VqW1Xvdi_0WZLm_8W94464HoAPsva7v49rNLJ46y7df146Hv9YlXVtG7VOfv7Y18DQYid</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72098053</pqid></control><display><type>article</type><title>Greater Occipital Nerve Blockade for Cluster Headache</title><source>Sage Journals GOLD Open Access 2024</source><creator>Peres, MFP ; Stiles, MA ; Siow, HC ; Rozen, TD ; Young, WB ; Silberstein, SD</creator><creatorcontrib>Peres, MFP ; Stiles, MA ; Siow, HC ; Rozen, TD ; Young, WB ; Silberstein, SD</creatorcontrib><description>Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P< 0.003, P = 0.003, P< 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache.</description><identifier>ISSN: 0333-1024</identifier><identifier>EISSN: 1468-2982</identifier><identifier>DOI: 10.1046/j.1468-2982.2002.00410.x</identifier><identifier>PMID: 12230593</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Aged ; Cluster headache ; Cluster Headache - drug therapy ; Cluster Headache - physiopathology ; Cluster Headache - therapy ; Female ; Humans ; Lidocaine - pharmacology ; Lidocaine - therapeutic use ; Male ; Middle Aged ; nerve block ; Nerve Block - methods ; Occipital Lobe - drug effects ; Occipital Lobe - physiology ; occipital nerve ; Statistics, Nonparametric ; Triamcinolone - pharmacology ; Triamcinolone - therapeutic use</subject><ispartof>Cephalalgia, 2002-09, Vol.22 (7), p.520-522</ispartof><rights>2002 International Headache Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</citedby><cites>FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1046/j.1468-2982.2002.00410.x$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1046/j.1468-2982.2002.00410.x$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,1411,21798,21945,27830,27901,27902,43597,43598,44921,45309,45550,45551</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1046/j.1468-2982.2002.00410.x?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12230593$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peres, MFP</creatorcontrib><creatorcontrib>Stiles, MA</creatorcontrib><creatorcontrib>Siow, HC</creatorcontrib><creatorcontrib>Rozen, TD</creatorcontrib><creatorcontrib>Young, WB</creatorcontrib><creatorcontrib>Silberstein, SD</creatorcontrib><title>Greater Occipital Nerve Blockade for Cluster Headache</title><title>Cephalalgia</title><addtitle>Cephalalgia</addtitle><description>Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P< 0.003, P = 0.003, P< 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache.</description><subject>Adult</subject><subject>Aged</subject><subject>Cluster headache</subject><subject>Cluster Headache - drug therapy</subject><subject>Cluster Headache - physiopathology</subject><subject>Cluster Headache - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Lidocaine - pharmacology</subject><subject>Lidocaine - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>nerve block</subject><subject>Nerve Block - methods</subject><subject>Occipital Lobe - drug effects</subject><subject>Occipital Lobe - physiology</subject><subject>occipital nerve</subject><subject>Statistics, Nonparametric</subject><subject>Triamcinolone - pharmacology</subject><subject>Triamcinolone - therapeutic use</subject><issn>0333-1024</issn><issn>1468-2982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkDtPwzAYRS0EouXxF1AmtoTPjzj2wABRaZEqygCz5TgOJKRNsRto_z0JqWCEyZbuudfWQSjAEGFg_KqKMOMiJFKQiACQCIB12fYAjX-CQzQGSmmIgbAROvG-AoCYAz9GI0wIhVjSMYqnzuqNdcHCmHJdbnQdPFj3YYPbujFvOrdB0bggrVvfQzOrc21e7Rk6KnTt7fn-PEXPd5OndBbOF9P79GYeGiY4hJriJBNYGpazgudFnhX9AJMmIUIXRMqcUY11ATgWlIhcWo4Flzzpkiwh9BRdDrtr17y31m_UsvTG1rVe2ab1KiEgBcS0A8UAGtd472yh1q5cardTGFSvTFWqN6N6M6pXpr6VqW1Xvdi_0WZLm_8W94464HoAPsva7v49rNLJ46y7df146Hv9YlXVtG7VOfv7Y18DQYid</recordid><startdate>200209</startdate><enddate>200209</enddate><creator>Peres, MFP</creator><creator>Stiles, MA</creator><creator>Siow, HC</creator><creator>Rozen, TD</creator><creator>Young, WB</creator><creator>Silberstein, SD</creator><general>SAGE Publications</general><general>Blackwell Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200209</creationdate><title>Greater Occipital Nerve Blockade for Cluster Headache</title><author>Peres, MFP ; Stiles, MA ; Siow, HC ; Rozen, TD ; Young, WB ; Silberstein, SD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cluster headache</topic><topic>Cluster Headache - drug therapy</topic><topic>Cluster Headache - physiopathology</topic><topic>Cluster Headache - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Lidocaine - pharmacology</topic><topic>Lidocaine - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>nerve block</topic><topic>Nerve Block - methods</topic><topic>Occipital Lobe - drug effects</topic><topic>Occipital Lobe - physiology</topic><topic>occipital nerve</topic><topic>Statistics, Nonparametric</topic><topic>Triamcinolone - pharmacology</topic><topic>Triamcinolone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peres, MFP</creatorcontrib><creatorcontrib>Stiles, MA</creatorcontrib><creatorcontrib>Siow, HC</creatorcontrib><creatorcontrib>Rozen, TD</creatorcontrib><creatorcontrib>Young, WB</creatorcontrib><creatorcontrib>Silberstein, SD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cephalalgia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Peres, MFP</au><au>Stiles, MA</au><au>Siow, HC</au><au>Rozen, TD</au><au>Young, WB</au><au>Silberstein, SD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Greater Occipital Nerve Blockade for Cluster Headache</atitle><jtitle>Cephalalgia</jtitle><addtitle>Cephalalgia</addtitle><date>2002-09</date><risdate>2002</risdate><volume>22</volume><issue>7</issue><spage>520</spage><epage>522</epage><pages>520-522</pages><issn>0333-1024</issn><eissn>1468-2982</eissn><abstract>Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P< 0.003, P = 0.003, P< 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>12230593</pmid><doi>10.1046/j.1468-2982.2002.00410.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 0333-1024 |
ispartof | Cephalalgia, 2002-09, Vol.22 (7), p.520-522 |
issn | 0333-1024 1468-2982 |
language | eng |
recordid | cdi_proquest_miscellaneous_72098053 |
source | Sage Journals GOLD Open Access 2024 |
subjects | Adult Aged Cluster headache Cluster Headache - drug therapy Cluster Headache - physiopathology Cluster Headache - therapy Female Humans Lidocaine - pharmacology Lidocaine - therapeutic use Male Middle Aged nerve block Nerve Block - methods Occipital Lobe - drug effects Occipital Lobe - physiology occipital nerve Statistics, Nonparametric Triamcinolone - pharmacology Triamcinolone - therapeutic use |
title | Greater Occipital Nerve Blockade for Cluster Headache |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T04%3A23%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Greater%20Occipital%20Nerve%20Blockade%20for%20Cluster%20Headache&rft.jtitle=Cephalalgia&rft.au=Peres,%20MFP&rft.date=2002-09&rft.volume=22&rft.issue=7&rft.spage=520&rft.epage=522&rft.pages=520-522&rft.issn=0333-1024&rft.eissn=1468-2982&rft_id=info:doi/10.1046/j.1468-2982.2002.00410.x&rft_dat=%3Cproquest_AFRWT%3E72098053%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72098053&rft_id=info:pmid/12230593&rft_sage_id=10.1046_j.1468-2982.2002.00410.x&rfr_iscdi=true |